Vanda Pharmaceuticals Inc. logo

Vanda Pharmaceuticals Inc.

VNDA | NASDAQ
Chart Builder DCF Calculator
$5.16
+$0.03 (+0.58%)
At close: Sep 21, 2026, 4:00 PM ET
$5.15
-$0.01 (-0.19%)
Pre-market: Sep 22, 2026, 7:33 AM ET

Market Data

Market Cap
$310M
Enterprise Value
$139.97M
Beta
0.65
Average Volume
968.35K
Shares Outstanding (Diluted)
60.23M
Shares Change YoY
2.09%
Institutional Ownership
77.74%
Exchange
NASDAQ
ISIN
US9216591084

Price Performance

Price Change 1M
-3.4%
Price Change 3M
-13.3%
Price Change 6M
-28.8%
Price Change YTD
-37.5%
Price Change 1Y
8.6%
Price Change 3Y
14.4%
Price Change 5Y
-70.1%
1M CAGR (ann.)
3.2%
1Y CAGR (ann.)
14.2%
5Y CAGR (ann.)
-20.9%
All-Time CAGR
-4.4%

Valuation

PE Ratio
-1.11
Forward PE
N/A
PEG Ratio
0.01
Forward PEG
0.02
PS Ratio
1.44
Forward PS
0.90
PB Ratio
1.41
P/FCF Ratio
-1.60
P/Adj. FCF Ratio
-1.51
P/OCF Ratio
-1.61
EV/Sales
0.65
EV/EBIT
-0.78
EV/EBITDA
-0.84
EV/FCF
-0.72
Earnings Yield
-89.7%
FCF Yield
-62.4%
Adj. FCF Yield
-66.2%

Financial Health

Net Cash
$170.03M
Total Debt
$0
Cash & Short-Term Investments
$170.03M
Total Assets
$412.47M
Current Ratio
1.61
Quick Ratio
1.60
Debt / Equity Ratio
0.10
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
-1.37
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
92.8%
Operating Profit Margin
-86.1%
EBITDA Margin
-77.2%
Net Profit Margin
-127.4%
FCF Margin
-89.7%
Adj. FCF Margin
-95.1%
SBC / Revenue
5.4%
SBC Impact (per share)
-6.0%

Returns

Return on Assets
-66.6%
Return on Equity
-85.0%
Return on Invested Capital
-73.4%
Return on Capital Employed
-74.7%
Return on Tangible Assets
-91.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
-3.3%
Revenue CAGR 5Y
-3.6%
Revenue CAGR 10Y
5.2%
EPS CAGR 3Y
-111.7%
EPS CAGR 5Y
-100.5%
EPS CAGR 10Y
-136.1%
FCF CAGR 3Y
-106.4%
FCF CAGR 5Y
-162.9%
FCF CAGR 10Y
-246.6%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
19
EPS Growth Next 3Y
33.2%
Revenue Growth Next 3Y
29.3%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
-$0.72
EPS Growth Est (next Q)
89.5%
Revenue Est (next Q)
$69.3M
Revenue Growth Est (next Q)
23.2%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$21
Price Target Upside
307.0%

Cash Flow

Operating Cash Flow
$-192.55M
Free Cash Flow
$-193.44M
Adj. Free Cash Flow
$-205.07M
FCF Per Share
-$3.21
OCF Per Share
-$3.20
OCF/S Ratio
-89.3%

Income Statement

Revenue
$215.72M
Gross Profit
$200.23M
Operating Income
$-185.67M
EBITDA
$-166.62M
Net Income
$-274.85M
EPS (Diluted)
-$4.63
Revenue / Employee
$404.73K
Profit / Employee
$-515.67K
Employees
533

© 2026 bestshares.com. All rights reserved.